In line with Icon’s national and international expansion, investment in research remains a priority. We are utilising our long history and depth of clinical trials experience in Australia to continue to establish new research at existing Icon sites and build upon proven team structures to bring the same level of world-class trials to our centres across New Zealand, Singapore and the United Kingdom.
View our achievements, milestones and future strategy in the our Annual Research Reports below.
Icon has a strong technical research culture, including research projects and collaborations with equipment vendors (such as Varian and Siemens), other clinical institutions and universities. These projects operate across nationally across Australian Icon cancer centres. This research often leads to implementation of new techniques or technology, as well as presentation at national and international conferences, or publication in international peer reviewed journals.
Icon currently collaborates with the following research agreements/projects:
Icon also has several internally led technical research projects relating to Halcyon™, HyperArc™, motion management and online adaptive radiation therapy and continues to foster our global partnership with Varian Medical Systems to advance radiation oncology.
Icon Group is Australia’s largest dedicated cancer care provider and has expanded globally into Singapore, Mainland China, Hong Kong and New Zealand.
People from across Icon Group share their stories of success, career progression and being iconic.
At Icon, you’ll help change lives, every single day. In return for your passion, dedication and agility, we offer a workplace where you can.
Read the latest news and updates across Icon Group.